Institutional Cluster

ACAD

ACADIA PHARMACEUTICALS INC
MIXED
Impact 5/10
Horizonweeks Processed1mo ago
Institutional cluster: 12 buyers, 7 sellers (mixed)
Actionable Insight ◆ Mixed

The institutional cluster is directionally mixed — heavy buying by Norges Bank, Citadel, and Goldman Sachs is offset by a massive near-exit from First Trust Advisors and significant trims by Deutsche Bank and RenTech. With no insider buying to corroborate the bull case and a poor historical track record of ACAD reports (avg -5.1% T+20), this is not a strong directional signal. Monitor for a catalyst (e.g., pipeline update or earnings) that could resolve the divergence; until then, the stock may remain range-bound.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+20d
ACAD ▼ -7.76% at T+20d
NEUTRAL call ✗ call lost -7.76% · α vs SPY -5.78% · entry $29.01 → $26.76
Next anchor: T+60d in 5w
Latest observation: T+31 -47.01% FF3 residual α
Entry anchored
Aug 14, 04:00 PM ET
via 1-min bar
T+1d
+4.03%
call +4.03% · α +4.71%
$30.18
settled 7w ago
T+5d
+2.21%
call +2.21% · α +3.40%
$29.65
settled 6w ago
T+20d
-7.76%
call -7.76% · α -5.78%
$26.76
settled 18d ago
T+60d
—
call — · α —
—
in 5w

Executive Summary

Institutional activity in ACAD during 2026-Q2 shows a mixed picture: 12 buyers accumulated $180.5M (net +$122.9M) led by Norges Bank ($41.1M new), Citadel ($41.3M added), and Goldman Sachs ($30.6M added), while 7 sellers reduced holdings by $90.9M, including a near-total exit by First Trust Advisors ($69.8M sold). The cluster is dominated by active managers and quants on the buy side, but the largest seller (First Trust) and a significant trim by Deutsche Bank ($12.2M) create a tug-of-war signal. Historical performance on ACAD reports has been poor (avg T+20 P&L -5.1%, 29% win rate), and the calibration data shows score-8 and score-9 calls have very low observed up-move probabilities (25% and 5% respectively), suggesting caution against over-scoring this cluster as a strong directional signal.

Key Financial Metrics

Direction
mixed
Buy Value
$180.5M
Sell Value
$90.9M
Net Flow
$31.9M

Institutional Positions

Net institutional flow: $31.9M

▲ Buyers (12)

InstitutionActionChangePosition ValueValue Δ
Norges BankNEW+0%$41.1M$41.1M
CitadelDOUBLED+250.4%$55.2M$41.3M
Goldman SachsADD+65.6%$65.3M$30.6M

▼ Sellers (7)

InstitutionActionChangePrev ValueValue Δ
First Trust AdvisorsNEAR_EXIT-94.5%$74.4M-$69.8M
Deutsche BankTRIM-69.3%$18.7M-$12.2M
RenTechTRIM-25.6%$38.4M-$5.9M

Key Facts

  • 12 institutional buyers accumulated $180.5M in ACAD during 2026-Q2, net +$122.9M
  • 7 institutional sellers reduced holdings by $90.9M, led by First Trust Advisors exiting 94.5% of its position ($69.8M sold)
  • Top buyers: Norges Bank (NEW, $41.1M), Citadel (DOUBLED, +$41.3M), Goldman Sachs (ADD, +$30.6M)
  • Top sellers: First Trust Advisors (NEAR_EXIT, -$69.8M), Deutsche Bank (TRIM, -$12.2M), RenTech (TRIM, -$5.9M)
  • No open-market insider buying corroborates the institutional accumulation (confluence score 22/100, divergent)
  • Historical reports on ACAD have underperformed: avg T+20 P&L -5.1%, 29% win rate on 7 settled reports

Financial Impact

12 institutions accumulated $180.5M in new/add/doubled positions while 7 institutions reduced holdings by $90.9M, for net institutional buying of approximately $31.9M

institutional ownershipfloat

Risk Factors

  • First Trust Advisors' near-total exit ($69.8M sold) suggests a loss of conviction from a major holder
  • No insider buying to corroborate institutional accumulation
  • Historical ACAD reports have underperformed significantly (avg T+20 -5.1%, 29% win rate)
  • 13F data is 45+ days stale; positions may have been unwound since quarter-end

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ACAD-2026-Q2
9 reports for ACAD
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +5.01%May 6, 2026
Filters
Rows
Reports for ACAD — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$27.52 $26.40▼ −4.09%▼ −4.19%—
Aug 17, 2026
6w ago
Institutional Cluster
MIXED ★ 5/10
$29.01 $29.65▲ +2.21%▲ +3.40%—
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$29.39 $29.01▼ −1.29%▼ −1.25%—
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 6/10
$21.39 $21.60▼ −0.98%▼ −0.55%—
May 6, 2026
21w ago
8-K
BEARISH ★ 6/10
$22.56 $22.18▲ +1.68%▲ +3.19%—
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.19 $21.80▼ −1.76%▼ −4.69%—
Mar 25, 2026
27w ago
Insider Cluster
NEUTRAL ★ 4/10
$22.01 $22.32▲ +1.41%▲ +1.65%—
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$22.40 $21.27▼ −5.04%▼ −2.81%—
Feb 25, 2026
31w ago
8-K
BULLISH ★ 8/10
$24.64 $22.40▼ −9.09%▼ −7.96%—
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 17, 2026